103 related articles for article (PubMed ID: 4361279)
21. Immunologic identification of Epstein-Barr virus early antigen in a P3HR-1 cell extract.
Veltri RW; Wainwright WH; Sprinkle PM
J Natl Cancer Inst; 1976 Aug; 57(2):245-53. PubMed ID: 187767
[TBL] [Abstract][Full Text] [Related]
22. [Comparison of efficiency of various methods of induction of Epstein-Barr virus antigens synthesis in human lymphoblastoid cell lines].
Prachová K
Cesk Epidemiol Mikrobiol Imunol; 1982 Jul; 31(4):236-41. PubMed ID: 6288272
[No Abstract] [Full Text] [Related]
23. Induction of several new antigens, including a T cell-associated antigen, following conversion of the EBV-negative B cell line RAMOS to EHRB-RAMOS by Epstein-Barr virus.
Rosenthal KS; Shuman H; Strominger JL
J Immunol; 1981 Aug; 127(2):746-54. PubMed ID: 6166685
[No Abstract] [Full Text] [Related]
24. Induction of Epstein-Barr virus early antigen by phytohaemagglutinin in the presence of 5-iodo-2'-deoxyuridine: application to EBV serology.
Lenoir G; Tovey MG; Lavoue MF
J Immunol Methods; 1980; 34(1):23-9. PubMed ID: 6252264
[TBL] [Abstract][Full Text] [Related]
25. Immunofluorescent antigen associated with Epstein-Barr virus induced by 5-Iododeoxyuridine.
Sugawara K; Osato T
Nat New Biol; 1973 Nov; 246(151):72-3. PubMed ID: 4357309
[No Abstract] [Full Text] [Related]
26. Detection of virus and cellular-determined antigens in situ using [125I]protein A and autoradiography.
Moar MH; Rosén A; Klein G
J Immunol Methods; 1979; 30(3):219-29. PubMed ID: 227963
[TBL] [Abstract][Full Text] [Related]
27. Properties of a baboon lymphotropic herpesvirus related to Epstein-Barr virus.
Falk L; Deinhardt F; Nonoyama M; Wolfe LG; Bergholz C
Int J Cancer; 1976 Dec; 18(6):798-807. PubMed ID: 186420
[TBL] [Abstract][Full Text] [Related]
28. Antigen expression and colony formation of lymphoblastoid cell lines after superinfection with Epstein-Barr virus.
Rocchi G; Hewetson J; Henle W; Henle G
J Natl Cancer Inst; 1973 Feb; 50(2):307-14. PubMed ID: 4349762
[No Abstract] [Full Text] [Related]
29. Human antibodies to ovarian cancer antigens secreted by lymphoblastoid cell lines.
Al-Azzawi F; Stimson WH; Govan AD
J Clin Lab Immunol; 1987 Feb; 22(2):71-5. PubMed ID: 3037082
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus binding sites on lymphocyte subpopulations and the origin of lymphoblasts in cultured lymphoic cell lines and in the blood of patients with infectious mononucleosis.
Greaves MF; Brown G
Clin Immunol Immunopathol; 1975 Mar; 3(4):514-24. PubMed ID: 163715
[No Abstract] [Full Text] [Related]
31. Productive Epstein-Barr viral infection of the human lymphoblastoid cell line 6410 with release of early antigen inducing and transforming virus.
Traul KA; Stephens R; Gerber P; Peterson WD
Int J Cancer; 1977 Aug; 20(2):247-55. PubMed ID: 197026
[TBL] [Abstract][Full Text] [Related]
32. Sensitivity to EBV superinfection and IUdR inducibility of hybrid cells formed between a sensitive and a relatively resistant Burkitt lymphoma cell line.
Nyormoi O; Klein G; Adams A; Dombos L
Int J Cancer; 1973 Sep; 12(2):396-408. PubMed ID: 4365093
[No Abstract] [Full Text] [Related]
33. Increased T-cell responses to Epstein-Barr virus with high viral load in patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma.
Morishima S; Nakamura S; Yamamoto K; Miyauchi H; Kagami Y; Kinoshita T; Onoda H; Yatabe Y; Ito M; Miyamura K; Nagai H; Moritani S; Sugiura I; Tsushita K; Mihara H; Ohbayashi K; Iba S; Emi N; Okamoto M; Iwata S; Kimura H; Kuzushima K; Morishima Y
Leuk Lymphoma; 2015 Apr; 56(4):1072-8. PubMed ID: 24975317
[TBL] [Abstract][Full Text] [Related]
34. Lymphoblastoid cell lines and Burkitt-lymphoma-derived cell lines differ in the expression of a second Epstein-Barr virus encoded nuclear antigen.
Ernberg I; Kallin B; Dillner J; Falk K; Ehlin-Henriksson B; Hammarskjöld ML; Klein G
Int J Cancer; 1986 Nov; 38(5):729-37. PubMed ID: 3021635
[TBL] [Abstract][Full Text] [Related]
35. Relationship between Epstein-Barr virus-associated nuclear antigen and cell viability in human cell lines.
Suzuki M; Hinuma Y
Gan; 1975 Feb; 66(1):103-5. PubMed ID: 168112
[TBL] [Abstract][Full Text] [Related]
36. Production of antibody to human osteosarcoma associated antigens by continuous human lymphoblastoid cell lines.
Tsang KY; Pan JF; Fudenberg HH
Immunol Lett; 1984; 7(5):267-72. PubMed ID: 6202625
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus-induced lymphoblastoid cell lines from seropositive adult donors and their HLA-antigens.
Akiyama N; Ohsawa N; Kusaba R; Inou T; Takada M
Jpn J Exp Med; 1981 Feb; 51(1):1-7. PubMed ID: 6273617
[TBL] [Abstract][Full Text] [Related]
38. Differential inhibition of Epstein-Barr virus induction by the amino acid analogue, L-canavanine.
Yamamoto N; Mueller-Lantzsch N; zur Hausen H
Int J Cancer; 1980 Apr; 25(4):439-43. PubMed ID: 6246007
[TBL] [Abstract][Full Text] [Related]
39. Separation of the complement-fixing and early antigens from Epstein-Barr soluble antigen.
Wainwright WH; Veltri RW
J Natl Cancer Inst; 1977 Apr; 58(4):1111-3. PubMed ID: 66320
[TBL] [Abstract][Full Text] [Related]
40. Reactivity of Paul-Bunnell type heterophile antibody in sera from infectious mononucleosis patients with the surface of lymphoid cells carrying Epstein-Barr virus genomes.
Maeda M; Sairenji T; Hinuma Y
Microbiol Immunol; 1979; 23(12):1189-97. PubMed ID: 231730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
